nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—CYP2C9—brain cancer	0.629	1	CbGaD
Atazanavir—ABCC1—Etoposide—brain cancer	0.0859	0.372	CbGbCtD
Atazanavir—CYP3A4—Temozolomide—brain cancer	0.0605	0.262	CbGbCtD
Atazanavir—CYP3A4—Lomustine—brain cancer	0.0514	0.223	CbGbCtD
Atazanavir—ABCB1—Etoposide—brain cancer	0.0207	0.0898	CbGbCtD
Atazanavir—CYP3A4—Etoposide—brain cancer	0.0124	0.0538	CbGbCtD
Atazanavir—Lopinavir—CYP2C9—brain cancer	0.00188	0.404	CrCbGaD
Atazanavir—Ritonavir—CYP2C9—brain cancer	0.00158	0.339	CrCbGaD
Atazanavir—Saquinavir—CYP2C9—brain cancer	0.0012	0.257	CrCbGaD
Atazanavir—Cough—Procarbazine—brain cancer	0.000361	0.00267	CcSEcCtD
Atazanavir—Convulsion—Procarbazine—brain cancer	0.000359	0.00265	CcSEcCtD
Atazanavir—Hypertension—Procarbazine—brain cancer	0.000358	0.00264	CcSEcCtD
Atazanavir—Arthralgia—Procarbazine—brain cancer	0.000353	0.0026	CcSEcCtD
Atazanavir—Myalgia—Procarbazine—brain cancer	0.000353	0.0026	CcSEcCtD
Atazanavir—Anxiety—Procarbazine—brain cancer	0.000351	0.00259	CcSEcCtD
Atazanavir—Neutropenia—Carmustine—brain cancer	0.000348	0.00257	CcSEcCtD
Atazanavir—Dry mouth—Procarbazine—brain cancer	0.000345	0.00255	CcSEcCtD
Atazanavir—Confusional state—Procarbazine—brain cancer	0.000341	0.00252	CcSEcCtD
Atazanavir—Vomiting—Lomustine—brain cancer	0.000339	0.0025	CcSEcCtD
Atazanavir—Oedema—Procarbazine—brain cancer	0.000338	0.00249	CcSEcCtD
Atazanavir—Neutropenia—Temozolomide—brain cancer	0.000336	0.00248	CcSEcCtD
Atazanavir—Infection—Procarbazine—brain cancer	0.000336	0.00248	CcSEcCtD
Atazanavir—Hyperglycaemia—Carmustine—brain cancer	0.000336	0.00248	CcSEcCtD
Atazanavir—Angiopathy—Hydroxyurea—brain cancer	0.000334	0.00247	CcSEcCtD
Atazanavir—Shock—Procarbazine—brain cancer	0.000333	0.00245	CcSEcCtD
Atazanavir—Pollakiuria—Temozolomide—brain cancer	0.000332	0.00245	CcSEcCtD
Atazanavir—Erectile dysfunction—Temozolomide—brain cancer	0.000331	0.00244	CcSEcCtD
Atazanavir—Depression—Carmustine—brain cancer	0.000331	0.00244	CcSEcCtD
Atazanavir—Photosensitivity reaction—Temozolomide—brain cancer	0.000328	0.00242	CcSEcCtD
Atazanavir—Weight increased—Temozolomide—brain cancer	0.000327	0.00241	CcSEcCtD
Atazanavir—Hyperhidrosis—Procarbazine—brain cancer	0.000327	0.00241	CcSEcCtD
Atazanavir—Renal failure—Carmustine—brain cancer	0.000326	0.00241	CcSEcCtD
Atazanavir—Alopecia—Hydroxyurea—brain cancer	0.000325	0.0024	CcSEcCtD
Atazanavir—Weight decreased—Temozolomide—brain cancer	0.000325	0.0024	CcSEcCtD
Atazanavir—Neuropathy peripheral—Carmustine—brain cancer	0.000325	0.0024	CcSEcCtD
Atazanavir—Hyperglycaemia—Temozolomide—brain cancer	0.000324	0.00239	CcSEcCtD
Atazanavir—Stomatitis—Carmustine—brain cancer	0.000323	0.00239	CcSEcCtD
Atazanavir—Urinary tract infection—Carmustine—brain cancer	0.000322	0.00238	CcSEcCtD
Atazanavir—Anorexia—Procarbazine—brain cancer	0.000322	0.00238	CcSEcCtD
Atazanavir—Depression—Temozolomide—brain cancer	0.00032	0.00236	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000318	0.00234	CcSEcCtD
Atazanavir—Cardiac arrest—Etoposide—brain cancer	0.000316	0.00234	CcSEcCtD
Atazanavir—Nausea—Lomustine—brain cancer	0.000316	0.00233	CcSEcCtD
Atazanavir—Neuropathy peripheral—Temozolomide—brain cancer	0.000314	0.00232	CcSEcCtD
Atazanavir—Stomatitis—Temozolomide—brain cancer	0.000312	0.00231	CcSEcCtD
Atazanavir—Urinary tract infection—Temozolomide—brain cancer	0.000312	0.0023	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000308	0.00227	CcSEcCtD
Atazanavir—Insomnia—Procarbazine—brain cancer	0.000306	0.00226	CcSEcCtD
Atazanavir—Hepatobiliary disease—Temozolomide—brain cancer	0.000303	0.00224	CcSEcCtD
Atazanavir—Somnolence—Procarbazine—brain cancer	0.000301	0.00222	CcSEcCtD
Atazanavir—Ill-defined disorder—Hydroxyurea—brain cancer	0.000297	0.0022	CcSEcCtD
Atazanavir—Hypoaesthesia—Carmustine—brain cancer	0.000296	0.00219	CcSEcCtD
Atazanavir—Hallucination—Carmustine—brain cancer	0.000296	0.00219	CcSEcCtD
Atazanavir—Decreased appetite—Procarbazine—brain cancer	0.000294	0.00217	CcSEcCtD
Atazanavir—Alanine aminotransferase increased—Etoposide—brain cancer	0.000294	0.00217	CcSEcCtD
Atazanavir—Oedema peripheral—Carmustine—brain cancer	0.000293	0.00216	CcSEcCtD
Atazanavir—Connective tissue disorder—Carmustine—brain cancer	0.000293	0.00216	CcSEcCtD
Atazanavir—Fatigue—Procarbazine—brain cancer	0.000291	0.00215	CcSEcCtD
Atazanavir—Malaise—Hydroxyurea—brain cancer	0.000289	0.00213	CcSEcCtD
Atazanavir—Pain—Procarbazine—brain cancer	0.000289	0.00213	CcSEcCtD
Atazanavir—Constipation—Procarbazine—brain cancer	0.000289	0.00213	CcSEcCtD
Atazanavir—Hepatitis—Temozolomide—brain cancer	0.000288	0.00212	CcSEcCtD
Atazanavir—Hypoaesthesia—Temozolomide—brain cancer	0.000286	0.00211	CcSEcCtD
Atazanavir—Hallucination—Temozolomide—brain cancer	0.000286	0.00211	CcSEcCtD
Atazanavir—Urinary tract disorder—Temozolomide—brain cancer	0.000284	0.0021	CcSEcCtD
Atazanavir—Oedema peripheral—Temozolomide—brain cancer	0.000283	0.00209	CcSEcCtD
Atazanavir—Connective tissue disorder—Temozolomide—brain cancer	0.000283	0.00209	CcSEcCtD
Atazanavir—Urethral disorder—Temozolomide—brain cancer	0.000282	0.00208	CcSEcCtD
Atazanavir—Feeling abnormal—Procarbazine—brain cancer	0.000279	0.00206	CcSEcCtD
Atazanavir—Eye disorder—Carmustine—brain cancer	0.000278	0.00205	CcSEcCtD
Atazanavir—Convulsion—Hydroxyurea—brain cancer	0.000278	0.00205	CcSEcCtD
Atazanavir—Gastrointestinal pain—Procarbazine—brain cancer	0.000276	0.00204	CcSEcCtD
Atazanavir—Erythema multiforme—Temozolomide—brain cancer	0.000272	0.00201	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000271	0.002	CcSEcCtD
Atazanavir—Discomfort—Hydroxyurea—brain cancer	0.00027	0.00199	CcSEcCtD
Atazanavir—Neutropenia—Etoposide—brain cancer	0.000269	0.00198	CcSEcCtD
Atazanavir—Eye disorder—Temozolomide—brain cancer	0.000269	0.00198	CcSEcCtD
Atazanavir—Urticaria—Procarbazine—brain cancer	0.000269	0.00198	CcSEcCtD
Atazanavir—Tinnitus—Temozolomide—brain cancer	0.000268	0.00198	CcSEcCtD
Atazanavir—Body temperature increased—Procarbazine—brain cancer	0.000267	0.00197	CcSEcCtD
Atazanavir—Abdominal pain—Procarbazine—brain cancer	0.000267	0.00197	CcSEcCtD
Atazanavir—Cardiac disorder—Temozolomide—brain cancer	0.000267	0.00197	CcSEcCtD
Atazanavir—Alopecia—Carmustine—brain cancer	0.000263	0.00194	CcSEcCtD
Atazanavir—Oedema—Hydroxyurea—brain cancer	0.000262	0.00193	CcSEcCtD
Atazanavir—Angiopathy—Temozolomide—brain cancer	0.000261	0.00193	CcSEcCtD
Atazanavir—Mental disorder—Carmustine—brain cancer	0.000261	0.00192	CcSEcCtD
Atazanavir—Infection—Hydroxyurea—brain cancer	0.00026	0.00192	CcSEcCtD
Atazanavir—Immune system disorder—Temozolomide—brain cancer	0.00026	0.00192	CcSEcCtD
Atazanavir—Mediastinal disorder—Temozolomide—brain cancer	0.000259	0.00191	CcSEcCtD
Atazanavir—Malnutrition—Carmustine—brain cancer	0.000259	0.00191	CcSEcCtD
Atazanavir—Nervous system disorder—Hydroxyurea—brain cancer	0.000257	0.00189	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000254	0.00188	CcSEcCtD
Atazanavir—Alopecia—Temozolomide—brain cancer	0.000254	0.00188	CcSEcCtD
Atazanavir—Skin disorder—Hydroxyurea—brain cancer	0.000254	0.00188	CcSEcCtD
Atazanavir—Renal failure—Etoposide—brain cancer	0.000252	0.00186	CcSEcCtD
Atazanavir—Mental disorder—Temozolomide—brain cancer	0.000252	0.00186	CcSEcCtD
Atazanavir—Neuropathy peripheral—Etoposide—brain cancer	0.000251	0.00186	CcSEcCtD
Atazanavir—Back pain—Carmustine—brain cancer	0.000251	0.00185	CcSEcCtD
Atazanavir—Malnutrition—Temozolomide—brain cancer	0.00025	0.00185	CcSEcCtD
Atazanavir—Stomatitis—Etoposide—brain cancer	0.00025	0.00184	CcSEcCtD
Atazanavir—Jaundice—Etoposide—brain cancer	0.00025	0.00184	CcSEcCtD
Atazanavir—Anorexia—Hydroxyurea—brain cancer	0.000249	0.00184	CcSEcCtD
Atazanavir—Hypersensitivity—Procarbazine—brain cancer	0.000249	0.00184	CcSEcCtD
Atazanavir—Dysgeusia—Temozolomide—brain cancer	0.000245	0.00181	CcSEcCtD
Atazanavir—Asthenia—Procarbazine—brain cancer	0.000243	0.00179	CcSEcCtD
Atazanavir—Hepatobiliary disease—Etoposide—brain cancer	0.000243	0.00179	CcSEcCtD
Atazanavir—Back pain—Temozolomide—brain cancer	0.000242	0.00179	CcSEcCtD
Atazanavir—Pruritus—Procarbazine—brain cancer	0.000239	0.00177	CcSEcCtD
Atazanavir—Agitation—Carmustine—brain cancer	0.000238	0.00176	CcSEcCtD
Atazanavir—Dyspnoea—Hydroxyurea—brain cancer	0.000233	0.00172	CcSEcCtD
Atazanavir—Somnolence—Hydroxyurea—brain cancer	0.000233	0.00172	CcSEcCtD
Atazanavir—Ill-defined disorder—Temozolomide—brain cancer	0.000232	0.00171	CcSEcCtD
Atazanavir—Diarrhoea—Procarbazine—brain cancer	0.000231	0.00171	CcSEcCtD
Atazanavir—Dyspepsia—Hydroxyurea—brain cancer	0.00023	0.0017	CcSEcCtD
Atazanavir—Agitation—Temozolomide—brain cancer	0.00023	0.0017	CcSEcCtD
Atazanavir—Hypoaesthesia—Etoposide—brain cancer	0.000229	0.00169	CcSEcCtD
Atazanavir—Angioedema—Temozolomide—brain cancer	0.000229	0.00169	CcSEcCtD
Atazanavir—Decreased appetite—Hydroxyurea—brain cancer	0.000227	0.00168	CcSEcCtD
Atazanavir—Urinary tract disorder—Etoposide—brain cancer	0.000227	0.00168	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000226	0.00167	CcSEcCtD
Atazanavir—Malaise—Temozolomide—brain cancer	0.000226	0.00167	CcSEcCtD
Atazanavir—Urethral disorder—Etoposide—brain cancer	0.000226	0.00167	CcSEcCtD
Atazanavir—Fatigue—Hydroxyurea—brain cancer	0.000226	0.00166	CcSEcCtD
Atazanavir—Convulsion—Carmustine—brain cancer	0.000225	0.00166	CcSEcCtD
Atazanavir—Hypertension—Carmustine—brain cancer	0.000224	0.00165	CcSEcCtD
Atazanavir—Constipation—Hydroxyurea—brain cancer	0.000224	0.00165	CcSEcCtD
Atazanavir—Pain—Hydroxyurea—brain cancer	0.000224	0.00165	CcSEcCtD
Atazanavir—Dizziness—Procarbazine—brain cancer	0.000224	0.00165	CcSEcCtD
Atazanavir—Palpitations—Temozolomide—brain cancer	0.000221	0.00163	CcSEcCtD
Atazanavir—Chest pain—Carmustine—brain cancer	0.000221	0.00163	CcSEcCtD
Atazanavir—Myalgia—Carmustine—brain cancer	0.000221	0.00163	CcSEcCtD
Atazanavir—Anxiety—Carmustine—brain cancer	0.00022	0.00162	CcSEcCtD
Atazanavir—Cough—Temozolomide—brain cancer	0.000219	0.00161	CcSEcCtD
Atazanavir—Erythema multiforme—Etoposide—brain cancer	0.000218	0.00161	CcSEcCtD
Atazanavir—Convulsion—Temozolomide—brain cancer	0.000217	0.0016	CcSEcCtD
Atazanavir—Hypertension—Temozolomide—brain cancer	0.000216	0.0016	CcSEcCtD
Atazanavir—Feeling abnormal—Hydroxyurea—brain cancer	0.000216	0.00159	CcSEcCtD
Atazanavir—Eye disorder—Etoposide—brain cancer	0.000215	0.00159	CcSEcCtD
Atazanavir—Vomiting—Procarbazine—brain cancer	0.000215	0.00159	CcSEcCtD
Atazanavir—Cardiac disorder—Etoposide—brain cancer	0.000214	0.00158	CcSEcCtD
Atazanavir—Confusional state—Carmustine—brain cancer	0.000213	0.00157	CcSEcCtD
Atazanavir—Arthralgia—Temozolomide—brain cancer	0.000213	0.00157	CcSEcCtD
Atazanavir—Myalgia—Temozolomide—brain cancer	0.000213	0.00157	CcSEcCtD
Atazanavir—Rash—Procarbazine—brain cancer	0.000213	0.00157	CcSEcCtD
Atazanavir—Dermatitis—Procarbazine—brain cancer	0.000213	0.00157	CcSEcCtD
Atazanavir—Anxiety—Temozolomide—brain cancer	0.000212	0.00157	CcSEcCtD
Atazanavir—Headache—Procarbazine—brain cancer	0.000212	0.00156	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000212	0.00156	CcSEcCtD
Atazanavir—Oedema—Carmustine—brain cancer	0.000212	0.00156	CcSEcCtD
Atazanavir—Discomfort—Temozolomide—brain cancer	0.000211	0.00155	CcSEcCtD
Atazanavir—Infection—Carmustine—brain cancer	0.00021	0.00155	CcSEcCtD
Atazanavir—Angiopathy—Etoposide—brain cancer	0.000209	0.00154	CcSEcCtD
Atazanavir—Dry mouth—Temozolomide—brain cancer	0.000209	0.00154	CcSEcCtD
Atazanavir—Immune system disorder—Etoposide—brain cancer	0.000208	0.00153	CcSEcCtD
Atazanavir—Mediastinal disorder—Etoposide—brain cancer	0.000207	0.00153	CcSEcCtD
Atazanavir—Body temperature increased—Hydroxyurea—brain cancer	0.000207	0.00153	CcSEcCtD
Atazanavir—Confusional state—Temozolomide—brain cancer	0.000206	0.00152	CcSEcCtD
Atazanavir—Oedema—Temozolomide—brain cancer	0.000204	0.00151	CcSEcCtD
Atazanavir—Alopecia—Etoposide—brain cancer	0.000203	0.0015	CcSEcCtD
Atazanavir—Infection—Temozolomide—brain cancer	0.000203	0.0015	CcSEcCtD
Atazanavir—Anorexia—Carmustine—brain cancer	0.000202	0.00149	CcSEcCtD
Atazanavir—Nausea—Procarbazine—brain cancer	0.000201	0.00148	CcSEcCtD
Atazanavir—Nervous system disorder—Temozolomide—brain cancer	0.0002	0.00148	CcSEcCtD
Atazanavir—Skin disorder—Temozolomide—brain cancer	0.000199	0.00147	CcSEcCtD
Atazanavir—Hyperhidrosis—Temozolomide—brain cancer	0.000198	0.00146	CcSEcCtD
Atazanavir—Dysgeusia—Etoposide—brain cancer	0.000196	0.00145	CcSEcCtD
Atazanavir—Anorexia—Temozolomide—brain cancer	0.000195	0.00144	CcSEcCtD
Atazanavir—Back pain—Etoposide—brain cancer	0.000194	0.00143	CcSEcCtD
Atazanavir—Hypersensitivity—Hydroxyurea—brain cancer	0.000193	0.00142	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Carmustine—brain cancer	0.000193	0.00142	CcSEcCtD
Atazanavir—Insomnia—Carmustine—brain cancer	0.000191	0.00141	CcSEcCtD
Atazanavir—Dyspnoea—Carmustine—brain cancer	0.000189	0.00139	CcSEcCtD
Atazanavir—Somnolence—Carmustine—brain cancer	0.000188	0.00139	CcSEcCtD
Atazanavir—Asthenia—Hydroxyurea—brain cancer	0.000188	0.00139	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000186	0.00137	CcSEcCtD
Atazanavir—Ill-defined disorder—Etoposide—brain cancer	0.000186	0.00137	CcSEcCtD
Atazanavir—Insomnia—Temozolomide—brain cancer	0.000185	0.00136	CcSEcCtD
Atazanavir—Decreased appetite—Carmustine—brain cancer	0.000184	0.00136	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Carmustine—brain cancer	0.000183	0.00135	CcSEcCtD
Atazanavir—Dyspnoea—Temozolomide—brain cancer	0.000182	0.00134	CcSEcCtD
Atazanavir—Somnolence—Temozolomide—brain cancer	0.000182	0.00134	CcSEcCtD
Atazanavir—Pain—Carmustine—brain cancer	0.000181	0.00133	CcSEcCtD
Atazanavir—Constipation—Carmustine—brain cancer	0.000181	0.00133	CcSEcCtD
Atazanavir—Malaise—Etoposide—brain cancer	0.000181	0.00133	CcSEcCtD
Atazanavir—Dyspepsia—Temozolomide—brain cancer	0.00018	0.00133	CcSEcCtD
Atazanavir—Diarrhoea—Hydroxyurea—brain cancer	0.000179	0.00132	CcSEcCtD
Atazanavir—Decreased appetite—Temozolomide—brain cancer	0.000178	0.00131	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Temozolomide—brain cancer	0.000176	0.0013	CcSEcCtD
Atazanavir—Fatigue—Temozolomide—brain cancer	0.000176	0.0013	CcSEcCtD
Atazanavir—Loss of consciousness—Etoposide—brain cancer	0.000176	0.0013	CcSEcCtD
Atazanavir—Cough—Etoposide—brain cancer	0.000175	0.00129	CcSEcCtD
Atazanavir—Constipation—Temozolomide—brain cancer	0.000175	0.00129	CcSEcCtD
Atazanavir—Pain—Temozolomide—brain cancer	0.000175	0.00129	CcSEcCtD
Atazanavir—Feeling abnormal—Carmustine—brain cancer	0.000174	0.00129	CcSEcCtD
Atazanavir—Convulsion—Etoposide—brain cancer	0.000174	0.00128	CcSEcCtD
Atazanavir—Hypertension—Etoposide—brain cancer	0.000173	0.00128	CcSEcCtD
Atazanavir—Dizziness—Hydroxyurea—brain cancer	0.000173	0.00128	CcSEcCtD
Atazanavir—Gastrointestinal pain—Carmustine—brain cancer	0.000173	0.00128	CcSEcCtD
Atazanavir—Chest pain—Etoposide—brain cancer	0.000171	0.00126	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000169	0.00125	CcSEcCtD
Atazanavir—Discomfort—Etoposide—brain cancer	0.000169	0.00124	CcSEcCtD
Atazanavir—Feeling abnormal—Temozolomide—brain cancer	0.000168	0.00124	CcSEcCtD
Atazanavir—Abdominal pain—Carmustine—brain cancer	0.000167	0.00123	CcSEcCtD
Atazanavir—Body temperature increased—Carmustine—brain cancer	0.000167	0.00123	CcSEcCtD
Atazanavir—Gastrointestinal pain—Temozolomide—brain cancer	0.000167	0.00123	CcSEcCtD
Atazanavir—Vomiting—Hydroxyurea—brain cancer	0.000166	0.00123	CcSEcCtD
Atazanavir—Rash—Hydroxyurea—brain cancer	0.000165	0.00122	CcSEcCtD
Atazanavir—Confusional state—Etoposide—brain cancer	0.000165	0.00122	CcSEcCtD
Atazanavir—Dermatitis—Hydroxyurea—brain cancer	0.000165	0.00122	CcSEcCtD
Atazanavir—Headache—Hydroxyurea—brain cancer	0.000164	0.00121	CcSEcCtD
Atazanavir—Infection—Etoposide—brain cancer	0.000162	0.0012	CcSEcCtD
Atazanavir—Urticaria—Temozolomide—brain cancer	0.000162	0.0012	CcSEcCtD
Atazanavir—Body temperature increased—Temozolomide—brain cancer	0.000162	0.00119	CcSEcCtD
Atazanavir—Abdominal pain—Temozolomide—brain cancer	0.000162	0.00119	CcSEcCtD
Atazanavir—Skin disorder—Etoposide—brain cancer	0.000159	0.00117	CcSEcCtD
Atazanavir—Hyperhidrosis—Etoposide—brain cancer	0.000158	0.00117	CcSEcCtD
Atazanavir—Anorexia—Etoposide—brain cancer	0.000156	0.00115	CcSEcCtD
Atazanavir—Hypersensitivity—Carmustine—brain cancer	0.000156	0.00115	CcSEcCtD
Atazanavir—Nausea—Hydroxyurea—brain cancer	0.000155	0.00115	CcSEcCtD
Atazanavir—Asthenia—Carmustine—brain cancer	0.000152	0.00112	CcSEcCtD
Atazanavir—Hypersensitivity—Temozolomide—brain cancer	0.000151	0.00111	CcSEcCtD
Atazanavir—Asthenia—Temozolomide—brain cancer	0.000147	0.00108	CcSEcCtD
Atazanavir—Dyspnoea—Etoposide—brain cancer	0.000146	0.00108	CcSEcCtD
Atazanavir—Somnolence—Etoposide—brain cancer	0.000145	0.00107	CcSEcCtD
Atazanavir—Diarrhoea—Carmustine—brain cancer	0.000145	0.00107	CcSEcCtD
Atazanavir—Pruritus—Temozolomide—brain cancer	0.000145	0.00107	CcSEcCtD
Atazanavir—Decreased appetite—Etoposide—brain cancer	0.000142	0.00105	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Etoposide—brain cancer	0.000141	0.00104	CcSEcCtD
Atazanavir—Fatigue—Etoposide—brain cancer	0.000141	0.00104	CcSEcCtD
Atazanavir—Dizziness—Carmustine—brain cancer	0.00014	0.00103	CcSEcCtD
Atazanavir—Constipation—Etoposide—brain cancer	0.00014	0.00103	CcSEcCtD
Atazanavir—Pain—Etoposide—brain cancer	0.00014	0.00103	CcSEcCtD
Atazanavir—Diarrhoea—Temozolomide—brain cancer	0.00014	0.00103	CcSEcCtD
Atazanavir—Dizziness—Temozolomide—brain cancer	0.000135	0.000997	CcSEcCtD
Atazanavir—Feeling abnormal—Etoposide—brain cancer	0.000135	0.000995	CcSEcCtD
Atazanavir—Vomiting—Carmustine—brain cancer	0.000134	0.000992	CcSEcCtD
Atazanavir—Gastrointestinal pain—Etoposide—brain cancer	0.000134	0.000987	CcSEcCtD
Atazanavir—Rash—Carmustine—brain cancer	0.000133	0.000984	CcSEcCtD
Atazanavir—Dermatitis—Carmustine—brain cancer	0.000133	0.000983	CcSEcCtD
Atazanavir—Headache—Carmustine—brain cancer	0.000133	0.000978	CcSEcCtD
Atazanavir—Vomiting—Temozolomide—brain cancer	0.00013	0.000959	CcSEcCtD
Atazanavir—Urticaria—Etoposide—brain cancer	0.00013	0.000959	CcSEcCtD
Atazanavir—Abdominal pain—Etoposide—brain cancer	0.000129	0.000954	CcSEcCtD
Atazanavir—Body temperature increased—Etoposide—brain cancer	0.000129	0.000954	CcSEcCtD
Atazanavir—Rash—Temozolomide—brain cancer	0.000129	0.000951	CcSEcCtD
Atazanavir—Dermatitis—Temozolomide—brain cancer	0.000129	0.00095	CcSEcCtD
Atazanavir—Headache—Temozolomide—brain cancer	0.000128	0.000945	CcSEcCtD
Atazanavir—Nausea—Carmustine—brain cancer	0.000126	0.000927	CcSEcCtD
Atazanavir—Nausea—Temozolomide—brain cancer	0.000121	0.000896	CcSEcCtD
Atazanavir—Hypersensitivity—Etoposide—brain cancer	0.000121	0.000889	CcSEcCtD
Atazanavir—Asthenia—Etoposide—brain cancer	0.000117	0.000866	CcSEcCtD
Atazanavir—Pruritus—Etoposide—brain cancer	0.000116	0.000854	CcSEcCtD
Atazanavir—Diarrhoea—Etoposide—brain cancer	0.000112	0.000826	CcSEcCtD
Atazanavir—Dizziness—Etoposide—brain cancer	0.000108	0.000798	CcSEcCtD
Atazanavir—Vomiting—Etoposide—brain cancer	0.000104	0.000767	CcSEcCtD
Atazanavir—Rash—Etoposide—brain cancer	0.000103	0.000761	CcSEcCtD
Atazanavir—Dermatitis—Etoposide—brain cancer	0.000103	0.00076	CcSEcCtD
Atazanavir—Headache—Etoposide—brain cancer	0.000102	0.000756	CcSEcCtD
Atazanavir—Nausea—Etoposide—brain cancer	9.72e-05	0.000717	CcSEcCtD
